Ngā hua rapu - Vallera, D A
- E whakaatu ana i te 1 - 6 hua o te 6
-
1
CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen r... mā Blazar, B R, Taylor, P A, Noelle, R J, Vallera, D A
I whakaputaina 1998Text -
2
-
3
Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity mā Stish, B J, Oh, S, Chen, H, Dudek, A Z, Kratzke, R A, Vallera, D A
I whakaputaina 2009Text -
4
Release of soluble "blocking" and "suppressor" factors from normal lymphocytes treated with RNA from spleens of tumour-bearing mice. mā Pennline, K. J., Evans, S. B., Nawrocki, J. F., Rees, J. C., Johnson, C. S., Vallera, D. A., Dodd, M. C.
I whakaputaina 1979Text -
5
The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated... mā Panoskaltsis-Mortari, A, Taylor, P A, Yaeger, T M, Wangensteen, O D, Bitterman, P B, Ingbar, D H, Vallera, D A, Blazar, B R
I whakaputaina 1997Text -
6
Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. mā Murphy, W J, Welniak, L A, Taub, D D, Wiltrout, R H, Taylor, P A, Vallera, D A, Kopf, M, Young, H, Longo, D L, Blazar, B R
I whakaputaina 1998Text